A cohort study found that mutations along the GDNF-RET signalling pathway are present in about 5% of patients with CAKUT and that the nature of the mutations affects the penetrance of CAKUT clinical presentation (Chatterjee et al., 2012). This evidence concerns the gene RET and congenital anomaly of kidney and urinary tract.